Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial
Launched by NEW YORK HOSPITAL QUEENS · Mar 8, 2010
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Babies born to mothers via elective CS: elective CS defined as planned CS in the absence of Labor.
- • Late preterm infants (34 1/7 to 36 6/7 weeks gestational age)
- Exclusion Criteria:
- • Presence of any of the risk factors for neonatal sepsis such as Prolonged Rupture of Membranes for ≥18 hours (PROM), maternal fever, maternal chorioamnionitis or positive maternal GBS colonization
- • Need for use of PPV for perinatal depression or other indications
- • Presence of any of the following
- • congenital malformations (diagnosed prenatally)
- • chromosomal anomalies (diagnosed prenatally)
- • congenital heart disease diagnosed by fetal echocardiography.
About New York Hospital Queens
New York Hospital Queens is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. With a commitment to innovation and excellence, the hospital actively sponsors clinical trials aimed at exploring new treatments and therapies across various medical fields. Its state-of-the-art facilities and a team of experienced researchers and healthcare professionals ensure that participants receive comprehensive care and support throughout the trial process. By fostering collaboration between physicians and researchers, New York Hospital Queens is at the forefront of medical advancements, contributing to improved patient outcomes and enhanced healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Flushing, New York, United States
Patients applied
Trial Officials
Pinchi Srinivasan, MD
Principal Investigator
New York Hospital Queens
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials